Correlation Between KB Financial and Celltrion Pharm

Can any of the company-specific risk be diversified away by investing in both KB Financial and Celltrion Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining KB Financial and Celltrion Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between KB Financial Group and Celltrion Pharm, you can compare the effects of market volatilities on KB Financial and Celltrion Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in KB Financial with a short position of Celltrion Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of KB Financial and Celltrion Pharm.

Diversification Opportunities for KB Financial and Celltrion Pharm

-0.33

Correlation Coefficient

KB Financial  Celltrion Pharm

Very good diversification

The 3 months correlation between 105560 and Celltrion is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding KB Financial Group and Celltrion Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Celltrion Pharm and KB Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on KB Financial Group are associated (or correlated) with Celltrion Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Celltrion Pharm has no effect on the direction of KB Financial i.e., KB Financial and Celltrion Pharm go up and down completely randomly.

Pair Corralation between KB Financial and Celltrion Pharm

Assuming the 90 days trading horizon KB Financial Group is expected to generate 0.95 times more return on investment than Celltrion Pharm. However, KB Financial Group is 1.05 times less risky than Celltrion Pharm. It trades about 0.06 of its potential returns per unit of risk. Celltrion Pharm is currently generating about -0.05 per unit of risk. If you would invest  8,040,500  in KB Financial Group on September 26, 2024 and sell it today you would earn a total of  609,500  from holding KB Financial Group or generate 7.58% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.39%
Values	Daily Returns

KB Financial Group  vs.  Celltrion Pharm

KB Financial Group

Risk-Adjusted Performance

4 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in KB Financial Group are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, KB Financial may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Celltrion Pharm

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Celltrion Pharm has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with KB Financial and Celltrion Pharm

The main advantage of trading using opposite KB Financial and Celltrion Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if KB Financial position performs unexpectedly, Celltrion Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celltrion Pharm will offset losses from the drop in Celltrion Pharm's long position.

The idea behind KB Financial Group and Celltrion Pharm pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.